We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01256762
Recruitment Status : Completed
First Posted : December 9, 2010
Last Update Posted : January 26, 2016
Sponsor:
Information provided by (Responsible Party):
Geron Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2012
  Study Completion Date : December 2012
  Certification or Request for Extension to Delay Results Submission: March 13, 2015